Core Insights - The company has confirmed its financial guidance for 2025, expecting organic revenue growth to range from -2% to +2%, an EBITA margin of 11% to 13%, and free cash flow of approximately DKK 800 million [2][7]. Hearing Division - The hearing aid market is projected to grow at 4-6% in volume, with GN expecting organic revenue growth of 5% to 9% in 2025, although it may be at the lower end due to a slower market growth assumption [3]. - The Hearing division achieved 7% organic revenue growth in the recent quarter, driven by strong sales of ReSound Vivia, resulting in a divisional profit margin of 34% [7]. Enterprise Division - The Enterprise division is facing challenges due to uncertainties in the trade environment, with expected organic revenue growth of -8% to 0% for 2025 [4]. - Despite these challenges, the division experienced positive sell-out growth outside of Europe, but organic revenue growth ended at -4% due to market uncertainties in Europe [7]. Gaming Division - The Gaming division is also affected by changes in the trade environment and weak consumer sentiment, with expected organic revenue growth of -6% to +2% for 2025 [5]. - The division delivered 3% organic growth in the recent quarter, achieving a profit margin of 9% despite tariff costs [7]. EBITA Margin and Financial Performance - The company has implemented significant actions to protect profitability, including diversifying the manufacturing footprint and adjusting prices in the U.S. [6]. - The reported EBITA for the quarter was DKK 435 million, resulting in an EBITA margin of 11%, reflecting revenue developments and strong cost control [7]. - Free cash flow, excluding M&A, was DKK 410 million, with net interest-bearing debt at DKK 9.4 billion, indicating a reported leverage of 4.0x [7][8].